Home › Funds › Orion Investment Co › REGN

Orion Investment Co position in REGN

REGENERON PHARMACEUTICALS · Health Care

Orion Investment Co reported holding 29,553 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$22.4M, representing 5.94% of its reported portfolio and ranking #4 among its reported holdings. Orion Investment Co has disclosed REGN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)29.55K sh
Reported value held$22.41M
Portfolio Weight5.94%
First reportedQ2 2024
Last changeHold
Updated2026-11-11

Last updated: 2026-11-11 · Source: SEC EDGAR Form 13F-HR

How Orion Investment Co's REGN position evolved

Orion Investment Co first disclosed a stake in REGN in Q2 2024 at 29,488 shares (US$31.0M). Across 10 filings, Orion Investment Co increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 29,553 shares valued at US$22.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 29.49K $30.99M New
Q3 2024 29.39K $30.89M Hold
Q4 2024 29.89K $21.29M Add
Q1 2025 30.56K $19.38M Add
Q2 2025 30.27K $15.89M Reduce
Q3 2025 30.64K $17.23M Add
Q4 2025 30.81K $23.78M Add
Q1 2026 30.84K $23.83M Hold
Q2 2026 29.50K $18.40M Reduce
Q3 2026 29.55K $22.41M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Orion Investment Co held REGN?

Orion Investment Co has disclosed REGN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Orion Investment Co's current position in REGN?

As of Q3 2026, Orion Investment Co holds 29.55K shares of REGN (REGENERON PHARMACEUTICALS), valued at $22.41M, representing 5.94% of its reported portfolio and ranking #4.

Has Orion Investment Co been buying or selling REGN?

In the latest 13F filing (Q3 2026), Orion Investment Co held unchanged its position in REGN.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Nuveen, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.